{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:13:48Z","timestamp":1789370028668,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fondo de Investigaciones Sanitarias","award":["PS09\/0193"],"award-info":[{"award-number":["PS09\/0193"]}]},{"name":"Fondo de Investigaciones Sanitarias","award":["PS11\/01780"],"award-info":[{"award-number":["PS11\/01780"]}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"\u201cMinisterio de Ciencia e Innovaci\u00f3n\u201d","doi-asserted-by":"crossref","award":["SAF2007-64062"],"award-info":[{"award-number":["SAF2007-64062"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"\u201cInstituto de Salud Carlos III\u201d","doi-asserted-by":"crossref","award":["RD06\/0001\/0001"],"award-info":[{"award-number":["RD06\/0001\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"\u201cInstituto de Salud Carlos III\u201d","doi-asserted-by":"crossref","award":["RD06\/0001\/1004"],"award-info":[{"award-number":["RD06\/0001\/1004"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jneuroim.2013.05.003","type":"journal-article","created":{"date-parts":[[2013,5,31]],"date-time":"2013-05-31T06:08:21Z","timestamp":1369980501000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Intrathecal injection of P\/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice"],"prefix":"10.1016","volume":"261","author":[{"given":"Elena","family":"Mart\u00edn-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Mannara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Guti\u00e9rrez-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Graus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.05.003_bb0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jnnp-2011-301506","article-title":"Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia","volume":"83","author":"Becker","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-001-0498-0","article-title":"Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis","volume":"103","author":"Bernal","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/B:JOBB.0000008029.22650.c5","article-title":"The voltage-gated calcium channel gamma subunits: a review of the literature","volume":"35","author":"Black","year":"2003","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0020","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.41.10.1682","article-title":"Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment","volume":"41","author":"Blumenfeld","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0030","first-page":"2819","article-title":"DNA vaccination with HuD inhibits growth of a neuroblastoma in mice","volume":"4","author":"Carpentier","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0035","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.42.10.1944","article-title":"Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome","volume":"42","author":"Clouston","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0040","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0045","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.10392","article-title":"Reduction of P\/Q-type calcium channels in the postmortem cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome","volume":"53","author":"Fukuda","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0060","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jnnp.57.9.1138","article-title":"Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects","volume":"57","author":"Goldstein","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0022-510X(91)90198-G","article-title":"Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model","author":"Graus","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0070","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.59.5.764","article-title":"P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer","volume":"59","author":"Graus","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0075","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jnnp.2006.091116","article-title":"Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia","volume":"78","author":"Ishida","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0022-510X(99)00125-2","article-title":"Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats","volume":"166","author":"Komai","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/14734220310017456","article-title":"The effects of cerebellar damage on maze learning in animals","volume":"2","author":"Lalonde","year":"2003","journal-title":"Cerebellum"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0095","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1073\/pnas.0710771105","article-title":"Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo","volume":"105","author":"Liao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0100","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1523\/JNEUROSCI.17-04-01339.1997","article-title":"Regional expression and cellular localization of the alpha1 and beta subunit of high voltage-activated calcium channels in rat brain","volume":"17","author":"Ludwig","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0105","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/120.8.1279","article-title":"Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert\u2013Eaton myasthenic syndrome","volume":"120","author":"Mason","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0110","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2004.01.028","article-title":"Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer","volume":"22","author":"Monstad","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/350398a0","article-title":"Primary structure and functional expression from complementary DNA of a brain calcium channel","volume":"350","author":"Mori","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(02)00063-2","article-title":"Linear B-cell epitopes in Lambert\u2013Eaton myasthenic syndrome defined by cell-free synthetic peptide binding","volume":"126","author":"Parsons","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0125","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nn.2369","article-title":"Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling","volume":"12","author":"Puighermanal","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0130","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0135","doi-asserted-by":"crossref","first-page":"e60438","DOI":"10.1371\/journal.pone.0060438","article-title":"Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer","volume":"8","author":"Sabater","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0140","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0145","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor","volume":"342","author":"Sillevis Smitt","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0155","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12311-011-0260-7","article-title":"The cerebellum and cognition: evidence from functional imaging studies","volume":"11","author":"Stoodley","year":"2012","journal-title":"Cerebellum"},{"key":"10.1016\/j.jneuroim.2013.05.003_bb0160","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/WNL.48.5.1261","article-title":"Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome","volume":"48","author":"Takamori","year":"1997","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:10Z","timestamp":1759047670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0165572813001355"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.05.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718016607.793486437","asserted-by":"object"}]},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrathecal injection of P\/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}